SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-04-009381
Filing Date
2004-10-19
Accepted
2004-10-19 06:41:25
Documents
2
Period of Report
2004-10-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS 8-K a4744248.txt 8-K 3397
2 ANTIGENICS EX-99.1 a4744248_ex991.txt EX-99.1 9310
  Complete submission text file 0001157523-04-009381.txt   14473
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 041084170
SIC: 2836 Biological Products, (No Diagnostic Substances)